Project ECHO^®: Rheumatologic Toxicities
with Immune Checkpoint Inhibitors

Telementoring To Manage Immune-related Adverse Events
in Patients Receiving Cancer Immunotherapies

Session 4 — Rheumatology

CME Information or Content Source:

Content Derived from a CME Certified Webinar in January 2023
Event Sponsor(s):

This activity is supported by an educational grant from Bristol Myers Squibb
Event Details:

Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC)

Date Recorded:

January 17, 2023
Recording Length:

54:51

Speakers

Casandra Calabrese, DO
Assistant Professor
Rheumatologic and Immunologic Disease
Infectious Disease
Taussig Cancer Center
Cleveland Clinic Foundation
Cleveland, OH

Laura S. Wood RN, MSN, OCN
Oncology Nurse Specialist
Medina, OH

Learning Objectives

At the end of this educational program, participants should be able to:

Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

Click here to learn about remaining Project ECHO sessions or to view other available recordings.